Clonidine Transdermal System, USP 0.1 mg/day, 4 patches per carton, Rx only, Manufactured by: Act...

FDA Recall #D-0235-2022 — Class III — October 28, 2021

Recall #D-0235-2022 Date: October 28, 2021 Classification: Class III Status: Terminated

Product Description

Clonidine Transdermal System, USP 0.1 mg/day, 4 patches per carton, Rx only, Manufactured by: Actavis Laboratories, UT Inc., Salt Lake City, UT, Distributed by: Actavis Pharma, Inc., Parsippany, NJ NDC 0591-3508-04

Reason for Recall

Failed Impurities/Degradation Specifications

Recalling Firm

Teva Pharmaceuticals USA — Parsippany, NJ

Classification

Class III — Not likely to cause adverse health consequences.

Product Type

Drugs

Product Quantity

64,978 patches

Distribution

Nationwide and Puerto Rico

Code Information

Lot# 1369117B, exp. date 11/2021

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated

What Should You Do?

Stop using this medication immediately and contact your pharmacist or doctor. Do not flush medications down the drain. Return the product to the place of purchase for a refund or replacement.

Back to All Drug Recalls